Endpoints at #JPM25 - January 13-14, 2025 - San Francisco
In the biopharma world, the new year doesn’t start on January 1 — it starts when the industry descends on San Francisco for JPM. Dealmakers, investors, and corporate leaders will gather to chart the course for 2025 and take stock of the landscape, both financial and political.
Endpoints News – Biotech and pharma business news, with a focus …
Biotech and pharma business news, with a focus on the science, people and money that drive the industry.
Bristol Myers’ TYK2 inhibitor succeeds in pair of Phase 3 psoriatic ...
Dec 23, 2024 · Bristol Myers Squibb’s bet on TYK2 continued to pay off Monday, as Sotyktu passed two more Phase 3 tests in psoriatic arthritis, the company announced …
The Endpoints 100 survey: What are biopharma execs saying …
Dec 11, 2024 · We’ve asked our advisory group in the E100 about how things are shaping up at the FDA and HHS under the new Trump administration and what impact prospective changes could have on the drug development industry. Also, they have insights on the tense China-US relations and drug development, AI and our continuing focus on financing at a critical …
Special report 2024: Meet 20 women breaking new ground in …
Oct 7, 2024 · Dedicated to the memory of Natalie Grover, who co-created the Women in Biopharma R&D special report while she was a reporter at Endpoints from 2018-2020. Natalie passed away earlier ...
Major PBM reforms feature in Congress’ year-end spending bill
Dec 17, 2024 · An end-of-year spending bill will include major reforms to the ways pharmacy benefit managers operate, including significant new restrictions on the fees and re ...
Big dreams dominate among next-gen biotech players
Born during a boom but virtually shunned on Wall Street today, this group of upstarts is out to defy some tough odds in birthing a biotech. Here’s John Carroll’s top picks for the next-gen players of 2022 most likely to make their mark — or go down fighting for a landmark change.
MASH drug developers chart path forward as more patients use …
Nov 4, 2024 · more like this. Eli Lilly's Omvoh earns FDA approval for Crohn's disease January 15, 2025; DEA issues proposed rule to permanently expand online prescribing of controlled ...
Endpoints at #ASCO24
Jun 4, 2024 · Each year, the oncology world looks to the ASCO meeting to make sense of the clinical cancer landscape. Data coming out of the meeting will signal pipeline strengths and weaknesses, and point to the next directions for cancer treatment. We’ll cover the biggest news out of the meeting and hear how oncology leaders see the field moving in the next year.</p>
The Endpoints 100 survey: What are industry execs saying about …
Twice a year, I run the Endpoints 100 survey, checking in with 100+ industry execs — mostly CEOs — about the state of biotech today. There have been good times, bad times and the last 18 months, which have left more than a few bruises.